rs2237583 — PON1 PON1 intron variant

Intronic PON1 variant that modulates arylesterase activity of the HDL-bound antioxidant enzyme paraoxonase-1, influencing protection against LDL oxidation and atherosclerosis

See your personal result for PON1

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

PON1's Hidden Regulator — How an Intronic Variant Shapes HDL's Antioxidant Power

Paraoxonase-1 (PON1) is one of the most important enzymes you've likely never heard of. It travels attached to HDL particles11 HDL particles
High-density lipoprotein, the "good cholesterol" that ferries cholesterol from tissues back to the liver in the bloodstream, where its primary job is to hydrolyze oxidized phospholipids22 oxidized phospholipids
Lipid peroxides that accumulate on LDL and artery walls, triggering the inflammatory cascade that leads to atherosclerotic plaque before they can damage artery walls. PON1 activity varies enormously between individuals — as much as 40-fold — and that variation is largely genetic. Most research focuses on the well-known coding variants Q192R (rs662) and L55M (rs854560), but a 2012 genome-wide analysis of the PON gene cluster found that intronic variants like rs2237583 contribute meaningfully to explaining that activity gap.

The Mechanism

rs2237583 sits in an intron of PON1 — a non-coding stretch between exons — and does not change any amino acid in the final protein. Instead, it appears to affect PON1 gene expression33 gene expression
The process by which DNA is transcribed into mRNA and then translated into protein; intronic variants can alter splicing efficiency, RNA stability, or regulatory element binding through regulatory mechanisms. The PON1 gene is transcribed on the minus strand of chromosome 7, and the rs2237583 T allele (plus strand) corresponds to the A allele in coding-strand notation. Carriers of the T allele show measurably higher PON1 arylesterase activity, which is the functional readout most tightly linked to HDL's capacity to protect LDL from oxidative modification. The T allele is the minor allele globally (~24–27% in European populations, ~63% in East Asians), meaning the majority of people carry the activity-limiting C allele.

The Evidence

Two large-scale genetic studies establish this variant's functional relevance. A comprehensive tag-SNP analysis of the PON gene cluster44 comprehensive tag-SNP analysis of the PON gene cluster
Kim et al. 2012. Additional Common Polymorphisms in the PON Gene Cluster Predict PON1 Activity but Not Vascular Disease. J Lipids. in 1,328 Caucasian males found that rs2237583 independently predicted arylesterase activity beyond the four established functional PON1 SNPs (β=+11.36 per T allele, p=2.82×10⁻⁴), explaining an additional 0.5% of total variance. All ten SNPs together explained 30.1% of activity variance. Critically, none of these activity-predicting SNPs — including rs2237583 — independently predicted carotid artery disease status in that cohort. A genome-wide association study of PON1 activity55 genome-wide association study of PON1 activity
Kim et al. 2013. Novel common and rare genetic determinants of paraoxonase activity. J Lipid Res. confirmed rs2237583 at genome-wide significance (p=3.88×10⁻⁸), underscoring its robust biological effect on enzyme activity.

The gap between "predicts PON1 activity" and "predicts cardiovascular events" is important context. The EPIC-Norfolk prospective study66 EPIC-Norfolk prospective study
Birjmohun et al. 2009. Both paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease. PLoS One. (1,138 CAD cases, 2,237 controls, 6-year follow-up) found that while PON1 activity inversely associated with CAD risk at the univariate level, this association disappeared after adjusting for HDL-C and HDL particle markers — suggesting PON1's protective effect is inseparable from the HDL that carries it, rather than being an independent causal factor. Yet prospective data from a high-risk cardiac catheterization cohort77 prospective data from a high-risk cardiac catheterization cohort
Bhattacharya et al. 2008. JAMA. (1,339 patients, 44-month follow-up) found stark outcome differences: the lowest PON1 activity quartile had 3.4-fold higher risk of major adverse cardiac events compared to the highest quartile (adjusted HR), and the QQ192 genotype (lower activity) was associated with HR 2.05 for all-cause mortality. The discrepancy likely reflects population differences — in a high-risk cohort, enzyme activity variation matters more.

Practical Implications

The T allele of rs2237583 is associated with modestly higher PON1 arylesterase activity, which in turn corresponds to slightly better HDL antioxidant function. The practical implication is not about an elevated cardiovascular risk so much as an opportunity: PON1 activity is highly modifiable by diet. A review of dietary PON1 modulators88 A review of dietary PON1 modulators
Goldberg et al. 2017. The Search for Dietary Supplements to Elevate or Activate Circulating Paraoxonases. Nutrients. found that pomegranate increased PON1 activity by 83% in patients with carotid artery stenosis over 12 months, quercetin by approximately 29% in serum, and catechins by up to 150% in hemodialyzed patients, though most human data comes from small or special-population studies. The mechanism involves polyphenols upregulating PON1 gene transcription through aryl hydrocarbon receptor signaling. Individuals carrying the common C allele (lower baseline activity) stand to gain the most from dietary optimization of PON1 function.

Interactions

rs2237583 acts within a multi-locus PON1 activity architecture. The four established functional SNPs — the Q192R (rs662) and L55M (rs854560) coding variants, plus two promoter polymorphisms (rs705379 and rs854571) — together explain ~25% of PON1 activity variance; rs2237583 adds an additional 0.5% independently. In the Kim et al. 2012 stepwise regression99 Kim et al. 2012 stepwise regression
Kim DS et al. Additional Common Polymorphisms in the PON Gene Cluster. J Lipids., rs2237583 and the other intronic SNPs were in low linkage disequilibrium (r²<0.60) with each other and with the coding variants, suggesting they capture distinct regulatory signals. The combined genotype across multiple PON1 loci determines an individual's overall PON1 activity phenotype — someone unfavorable at rs2237583, rs662 (QQ), and rs705379 simultaneously would have substantially lower activity than the sum of individual effects. PON1 activity also interacts with dietary polyphenol intake in a nutrigenetic relationship: a nutrigenetic observational study1010 nutrigenetic observational study
Rosales-Corral et al. 2016. Interaction between polyphenols intake and PON1 gene variants on markers of cardiovascular disease. J Transl Med. found that the relationship between polyphenol consumption and cardiovascular disease markers differed significantly by PON1 genotype, with low-activity genotypes benefiting more from high polyphenol intakes.

Nutrient Interactions

polyphenols altered_metabolism

Genotype Interpretations

What each possible genotype means for this variant.

CC Standard PON1 Activity Normal

Common genotype with baseline PON1 antioxidant enzyme activity

You carry two copies of the C allele at rs2237583, the most common genotype globally (approximately 56% of the population based on Hardy-Weinberg from a ~74% C allele frequency). This is the GRCh38 reference genotype. Your PON1 arylesterase activity is at the population baseline for this intronic locus — you do not have the additional activity boost conferred by one or two T alleles. In European populations the T allele frequency is ~27%, so roughly 56% of Europeans share this CC genotype. East Asians have a much higher T allele frequency (~63%), making CC considerably rarer there.

TT Higher PON1 Activity Beneficial

Two T alleles associated with the highest PON1 arylesterase activity at this locus

You carry two copies of the T allele at rs2237583, the rarest genotype at this locus (approximately 7% of the population globally, though ~40% in East Asian populations given their higher T allele frequency of ~63%). Based on the additive model established in 1,328 Caucasian males (β=+11.36 per allele), TT homozygotes have approximately 22 U/L higher arylesterase activity than CC individuals at this locus — a meaningful contribution to the wide variation in PON1 activity observed in the population. Your HDL's capacity to hydrolyze oxidized phospholipids and protect LDL from lipid peroxidation is enhanced.

CT Mildly Enhanced PON1 Activity Intermediate

One T allele provides a modest boost to PON1 arylesterase activity

You carry one copy of the T allele at rs2237583, a genotype present in approximately 37% of the population. Research in 1,328 Caucasian males found that each T allele adds roughly +11.36 U/L to arylesterase activity (p=2.82×10⁻⁴), representing a modest but statistically robust increase in PON1 function beyond baseline. Your HDL's antioxidant capacity is modestly enhanced compared to CC homozygotes, though the single allele effect is smaller than that conferred by the better-studied Q192R or promoter variants.